Recruiting Prostate Cancer Studies in Lexington
Pembro With Radiation With or Without Olaparib
This trial will evaluate whether the immune-sensitizing effects of immunotherapy (Pembrolizumab) and radiation with or without a PARP-inhibitor (Olaparib) will increase the effects of immunotherapy in...
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
This phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places in the body (metastati...
About Prostate Cancer Clinical Trials in Lexington
Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.
There are currently 2 prostate cancer clinical trials recruiting participants in Lexington, KY. These studies are seeking a combined 94 participants. Research is being sponsored by Zin W Myint, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.
Prostate Cancer Clinical Trials in Lexington — FAQ
Are there prostate cancer clinical trials in Lexington?
Yes, there are 2 prostate cancer clinical trials currently recruiting in Lexington, KY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lexington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lexington research site will contact you about next steps.
Are clinical trials in Lexington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lexington studies also compensate for your time and travel.
What prostate cancer treatments are being tested?
The 2 active trials in Lexington are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.
Data updated March 2, 2026 from ClinicalTrials.gov